JILIN PROVINCE XIDIAN PHARMACEUTICAL SCI-TECH DEVELOPMENT CO.,LTD

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

301130

CNE1000058C4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 15/07/2024 BST			5-day change	1st Jan Change
23.1 ^CNY	-0.04%		-0.26%	-17.14%

07-01	Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.	CI
06-04	Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 12 June 2024	CI

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Dividend for 2021

April 25, 2022 at 08:37 pm

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd announced on 25 April 2022 the profit distribution proposal for 2021. For the period the Company proposed final Cash dividend/10 shares (tax included): CNY 1.30000000.

Latest news about Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.	07-01	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 12 June 2024	06-04	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for 2023	05-27	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.	04-01	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 23, 2024.	02-29	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Executive Appointments	04/08/23	CI
Xidian Pharmaceutical’s Depression Drug Added to Procurement Program	04/08/23	MT
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for 2022, Payable on June 12, 2023	31/05/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Cash Dividend for the Year 2022	21/04/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	21/04/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	21/04/23	CI
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-FEB-2023.	23/02/23	CI
Xidian Pharma's Shareholder and Party Acting in Concert Plan to Unload Stake	02/02/23	CI
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-JAN-2023.	23/01/23	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 30 June 2022	23/06/22	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for the Year 2021	27/05/22	CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Dividend for 2021	25/04/22	CI

Chart Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

Duration

Period

Chart Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

More charts

Company Profile

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of chemical active pharmaceutical ingredients (APIs) and preparations. The Company's products cover the fields of anti anemia drugs, drugs for the treatment of mental disorders and the production of APIs, such as compound ferrous sulfate folic acid tablets, risperidone orally disintegrating tablets, escitalopram oxalate tablets, daphnetin capsules, sodium ferulate and ferrous fumarate.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JILIN PROVINCE XIDIAN PHARMACEUTICAL SCI-TECH DEVELOPMENT CO.,LTD	-17.14%	249M
ELI LILLY AND COMPANY	+62.82%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-4.02%	359B
MERCK & CO., INC.	+16.49%	325B
ABBVIE INC.	+8.82%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.40%	177B
PFIZER, INC.	+2.13%	165B